Dockets: 2005D-0042: Draft Guidance on the Open Public Hearing, FDA Advisory Committee Meetings

U.S. Food and Drug Administration

horizonal rule

2005D-0042: Draft Guidance on the Open Public Hearing, FDA Advisory Committee Meetings

		Document #			Received Date							Filed Date			Submitter Code					Submitter				FR Date		FR Page						Comment Date						Files			Remarks


		GDL1			02/15/2005							02/15/2005			Federal Government					Guidance																			pdf
																				Signature:		Guidance


		NAD1										02/14/2005			FDA					FDA				02/15/2005			7747-7747						06/15/2005						pdf
																				Signature:		HUBBARD, WILLIAM

		C1			04/06/2005							04/04/2005			Drug Industry					Sanofi Aventis																			pdf
																				Signature:		Steve Caffe, MD

		C2			06/21/2005							06/15/2005			Consumer Group					Public Citizen																			pdf
																				Signature:		Nicholas Stine et al.

Page last updated July 6, 2005 kk horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management